• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与中风相关的血液学和血管学概念。

Hematological and vascular concepts in relation to stroke.

作者信息

Didisheim P, Fuster V

出版信息

Clin Neurosurg. 1976;23:125-39. doi: 10.1093/neurosurgery/23.cn_suppl_1.125.

DOI:10.1093/neurosurgery/23.cn_suppl_1.125
PMID:975674
Abstract

This review has highlighted some of the factors which influence the formation and fate of thrombi. Rheology and flow, the coagulation mechanism, the fibrinolytic enzyme system, and the properties of platelets to adhere and aggregate all play a significant role. Of paramount importance to neurosurgeons is the role of the vascular wall in thrombogenesis. The ulcerated atherosclerotic plaque demonstrates this point. Factors contributing to thromboembolism in this setting include stenosis and reduced flow, turbulence, and the elements in the lesion with which blood interacts. These are principally collagen, ADP, fatty acids, and the thromboplastic activity of vascular subendothelial tissue. Current concepts of the etiologies of atherosclerosis were discussed. Along with other predisposing factors, platelets may play a significant role in the initiation of the process. The current status of clinical trials with inhibitors of platelet function in the treatment of cerebrovascular disorders was reviewed. In vascular reconstructive surgery, the principles which underlie good technique are those which best insure against thrombosis. The briefest possible period of stasis during surgery should be maintained. The reconstruction should result in a smooth blood flow pattern with rapid runoff and minimal stenosis or gaps between apposed endothelial surfaces.

摘要

本综述着重介绍了一些影响血栓形成及转归的因素。流变学与血流、凝血机制、纤维蛋白溶解酶系统以及血小板黏附与聚集的特性均发挥着重要作用。对神经外科医生而言至关重要的是血管壁在血栓形成过程中的作用。溃疡性动脉粥样硬化斑块就说明了这一点。在此情况下促成血栓栓塞的因素包括狭窄和血流减少、湍流以及血液与之相互作用的病变部位的成分。这些成分主要是胶原蛋白、二磷酸腺苷、脂肪酸以及血管内皮下组织的促凝血活性。文中讨论了动脉粥样硬化病因的当前概念。除其他诱发因素外,血小板可能在该过程的起始阶段发挥重要作用。综述了血小板功能抑制剂治疗脑血管疾病的临床试验现状。在血管重建手术中,良好技术所依据的原则是最能确保预防血栓形成的原则。手术期间应保持尽可能短的血流停滞时间。重建应形成平滑的血流模式,具有快速的血流流出,且相对的内皮表面之间的狭窄或间隙最小。

相似文献

1
Hematological and vascular concepts in relation to stroke.与中风相关的血液学和血管学概念。
Clin Neurosurg. 1976;23:125-39. doi: 10.1093/neurosurgery/23.cn_suppl_1.125.
2
Current issues in thrombosis prevention with antiplatelet drugs.抗血小板药物预防血栓形成的当前问题。
Drugs. 1986 Jun;31(6):517-49. doi: 10.2165/00003495-198631060-00004.
3
Platelet and antiplatelet agents in strokes.中风中的血小板与抗血小板药物
Stroke. 1978 Jul-Aug;9(4):403-5. doi: 10.1161/01.str.9.4.403.
4
[Antiplatelet therapy in patients with cerebral thrombosis at the chronic phase--assessment of its effect on coagulation and fibrinolytic parameters].[脑血栓形成患者慢性期的抗血小板治疗——评估其对凝血和纤溶参数的影响]
Rinsho Shinkeigaku. 1994 Aug;34(8):771-6.
5
[Platelet aggregation inhibiting treatment with aspirin. Biological bases. Application to cerebral vascular accidents].[阿司匹林抑制血小板聚集治疗。生物学基础。在脑血管意外中的应用]
Nouv Presse Med. 1972 Mar 25;1(13):863-8.
6
Management of thrombotic diseases.血栓性疾病的管理
Semin Hematol. 1971 Apr;8(2):95-139.
7
Platelet function tests in thrombotic cerebrovascular disorders.血栓性脑血管疾病中的血小板功能测试。
Stroke. 1983 Jul-Aug;14(4):511-7. doi: 10.1161/01.str.14.4.511.
8
[Antithrombotic agents, pharmacologic principles].[抗血栓形成药物,药理学原理]
Z Arztl Fortbild (Jena). 1986;80(14):565-70.
9
Mechanisms of cerebrovascular events as assessed by procoagulant activity, cerebral microemboli, and platelet microparticles in patients with prosthetic heart valves.人工心脏瓣膜置换患者中通过促凝血活性、脑微栓子和血小板微粒评估的脑血管事件机制
Stroke. 1998 Sep;29(9):1770-7. doi: 10.1161/01.str.29.9.1770.
10
Serum lipids, platelets, and fibrinolytic activity in cerebrovascular disease.脑血管疾病中的血脂、血小板及纤溶活性
Stroke. 1978 Mar-Apr;9(2):137-9. doi: 10.1161/01.str.9.2.137.

引用本文的文献

1
Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders.Asundexian(BAY 2433334)的设计与临床前特征研究计划,一种口服因子 XIa 抑制剂,用于预防和治疗血栓栓塞性疾病。
J Med Chem. 2023 Sep 14;66(17):12203-12224. doi: 10.1021/acs.jmedchem.3c00795. Epub 2023 Sep 5.